Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Betterlife Pharma Inc (BETR.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 01/31

(Values in thousands)

	01-2020	01-2019	01-2018	01-2017	01-2016
Cash Flows From Operating Activities
Depreciation Amortization	1,408	901	31	N/A	0
Accounts receivable	-93	N/A	N/A	N/A	N/A
Accounts payable and accrued liabilities	1,050	471	659	N/A	N/A
Other Working Capital	302	728	627	761	111
Other Operating Activity	-10,548	-7,077	-1,805	-1,256	-341
Operating Cash Flow	$-7,881	$-4,978	$-488	$-495	$-229

Cash Flows From Investing Activities
PPE Investments	-543	N/A	N/A	N/A	N/A
Net Acquisitions	-433	3	N/A	N/A	N/A
Purchase Sale Intangibles	0	-853	N/A	N/A	N/A
Other Investing Activity	-165	0	0	0	0
Investing Cash Flow	$-1,141	$-851	$N/A	$N/A	$N/A

Cash Flows From Financing Activities
Change In Short Term Borrowing	N/A	5,062	45	498	0
Debt Repayment	-3,834	-771	N/A	N/A	N/A
Common Stock Issued	16,310	1,536	400	0	336
Other Financing Activity	-250	0	0	24	0
Financing Cash Flow	$12,226	$5,827	$445	$522	$336

Exchange Rate Effect	2	-4	-16	27	-7
Beginning Cash Position	75	79	139	94	1
End Cash Position	3,282	75	80	147	100
Net Cash Flow	$3,205	$-1	$-43	$27	$106

Free Cash Flow
Operating Cash Flow	-7,881	-4,978	-488	-495	-229
Capital Expenditure	-543	-853	N/A	N/A	N/A
Free Cash Flow	-8,423	-5,831	-488	-495	-229